Steamboat Capital Partners LLC raised its holdings in shares of Tenet Healthcare Corporation (NYSE:THC – Free Report) by 59.5% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 79,074 shares of the company’s stock after purchasing an additional 29,490 shares during the period. Tenet Healthcare accounts for 3.2% of Steamboat Capital Partners LLC’s portfolio, making the stock its 8th largest position. Steamboat Capital Partners LLC owned approximately 0.10% of Tenet Healthcare worth $14,793,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently made changes to their positions in THC. Empirical Finance LLC bought a new stake in Tenet Healthcare during the 2nd quarter valued at about $586,000. Nykredit A S purchased a new stake in shares of Tenet Healthcare during the second quarter valued at approximately $600,000. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in shares of Tenet Healthcare during the second quarter valued at approximately $5,504,000. California State Teachers Retirement System lifted its position in Tenet Healthcare by 18,362.2% in the 2nd quarter. California State Teachers Retirement System now owns 18,885,726 shares of the company’s stock valued at $3,533,142,000 after acquiring an additional 18,783,432 shares in the last quarter. Finally, Compass Financial Management LLC purchased a new stake in Tenet Healthcare during the 2nd quarter valued at $57,000. Hedge funds and other institutional investors own 95.44% of the company’s stock.
Tenet Healthcare Stock Down 2.1%
NYSE THC opened at $259.37 on Wednesday. The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00. Tenet Healthcare Corporation has a 12 month low of $157.58 and a 12 month high of $283.05. The stock’s 50 day moving average is $241.08 and its 200 day moving average is $211.50. The stock has a market cap of $20.88 billion, a PE ratio of 10.00, a P/E/G ratio of 1.01 and a beta of 1.23.
Analyst Upgrades and Downgrades
Several equities research analysts recently commented on the company. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Tenet Healthcare in a research report on Monday, July 27th. Zacks Research upgraded shares of Tenet Healthcare from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. Barclays increased their price objective on shares of Tenet Healthcare from $240.00 to $271.00 and gave the company an “overweight” rating in a research report on Friday, July 24th. Royal Bank Of Canada lifted their target price on shares of Tenet Healthcare from $236.00 to $283.00 and gave the stock an “outperform” rating in a research report on Monday, July 27th. Finally, TD Cowen increased their price target on Tenet Healthcare from $233.00 to $263.00 and gave the company a “buy” rating in a report on Monday, July 27th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $273.00.
Get Our Latest Analysis on Tenet Healthcare
Insider Activity at Tenet Healthcare
In other news, EVP Lisa Y. Foo sold 24,000 shares of the business’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $266.32, for a total transaction of $6,391,680.00. Following the completion of the sale, the executive vice president directly owned 8,053 shares of the company’s stock, valued at approximately $2,144,674.96. The trade was a 74.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Tammy Romo sold 4,922 shares of the firm’s stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $264.15, for a total transaction of $1,300,146.30. Following the transaction, the director directly owned 30,784 shares in the company, valued at approximately $8,131,593.60. This trade represents a 13.78% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 109,189 shares of company stock valued at $29,264,109 over the last three months. Corporate insiders own 0.97% of the company’s stock.
About Tenet Healthcare
Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
Further Reading
- Five stocks we like better than Tenet Healthcare
- Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
- Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock
- Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement
- Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
